Company summary
Spire Healthcare operates one of the UK's largest networks of private hospitals and clinics, alongside a growing range of primary-care and occupational-health services. It treats private-pay, insured and NHS-funded patients.
← Back to the 350
SPI
Spire Healthcare
Health Care Equipment & Services
- Index
- FTSE 250
- ISIN
- Not specified
- Book status
- 2026 edition — current
Key activities
Private hospitals, surgery, diagnostics, outpatient treatment, NHS work, physiotherapy, occupational health, talking therapies and other primary-care services.
Key markets
The United Kingdom private healthcare market, with additional revenue from NHS contracts and employer-funded health services.
Key drivers
Private healthcare demand, NHS waiting lists, insured patient volumes, consultant recruitment, hospital utilisation, pricing, labour costs and efficiency savings.
Key risks
Clinical incidents, wage and agency costs, insurer pricing pressure, NHS policy changes, staffing shortages, regulation and high fixed operating costs.
Recent Developments
4 March 2026: FY2025 revenue rose 4.5% to £1.58bn and adjusted EBITDA increased 3.2% to £268.6m, supported by £30m of transformation savings. Interim results are due 9 September 2026, while Chair-designate Debbie White is due to succeed Sir Ian Cheshire by the end of September.
Dividend notes
Spire currently pays a modest annual dividend. The FY2025 final dividend was reduced to 1.5p per share, ex-dividend 21 May 2026 and paid 19 June; no further 2026 dividend has yet been declared.
The complete 350 Trade Book — 350 leading UK-listed companies, presented in one consistent working reference.